Foldable Intragastric Expander With Controlled Hydrogel Swelling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing ingestible devices for stomach volume reduction and satiety enhancement are temporary and invasive, lacking a controlled expansion mechanism and effective degradation process.

Innovation Solution

A biodegradable, self-expandable device with alternating fold axes and gel-forming material zones, designed to expand upon contact with stomach fluids, providing controlled volume reduction and satiety through a compact, foldable configuration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If the device is administered in a compact ingestible form, then it can be easily swallowed by the patient, but it occupies minimal volume in the stomach

Engineering Contradiction:
Improveease of swallowingVSAvoidstomach volume reduction
Core Design Contradiction:
Ease of operationVSVolume of stationary object

Solution Approach 1:

The device employs a nested structure where the gel-forming material is encapsulated within liquid-permeable layers, which are in turn contained within the foldable device structure. This nested arrangement allows the device to be administered in a compact form while containing the expansion mechanism that will later occupy stomach volume

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The device utilizes parameter changes through the gel-forming material that transitions from a compact state during administration to an expanded state upon contact with gastric fluids. This parameter change enables the device to overcome the contradiction between compact administration and volume occupation in the stomach

Inventive Principle:
Principle #35Parameter changes

2Productivity

If the device expands rapidly in the stomach, then it quickly reduces stomach volume and increases satiety, but it may cause discomfort or damage to the stomach walls

Engineering Contradiction:
Improveexpansion speedVSAvoidstomach wall damage
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The device employs liquid-permeable (porous) material layers that control the ingress of gastric fluids to the gel-forming material. This porous structure enables controlled expansion by regulating the rate at which the gel absorbs fluid, thus preventing rapid expansion that could harm stomach walls while still achieving effective volume reduction

Inventive Principle:
Principle #31Porous materials

Solution Approach 2:

The device structure includes folded segments and encapsulated gel material that act as a cushioning mechanism. The gradual expansion of the gel within the constrained folded structure provides a buffering effect, preventing sudden pressure spikes against the stomach walls while maintaining effective satiety induction

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

3Duration of action of moving object

If the device remains in the stomach for an extended period, then it provides prolonged satiety effect, but it increases the risk of degradation issues and complications

Engineering Contradiction:
Improvesatiety durationVSAvoiddegradation reliability
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The device is designed as a temporary, disposable implant that provides satiety effect for a limited duration before intentional degradation. This approach prioritizes reliability by ensuring the device degrades after serving its purpose, eliminating long-term retention risks while maintaining effective satiety induction during the operational period

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The device incorporates mechanisms for periodic degradation through intentional design features that allow controlled breakdown after a predetermined period. This periodic action ensures the device maintains structural integrity during the satiety induction period while reliably degrading afterward to prevent complications

Inventive Principle:
Principle #19Periodic action

4Reliability

If the device uses a complex expansion mechanism, then it achieves controlled and reliable expansion, but it increases device complexity and manufacturing difficulty

Engineering Contradiction:
Improveexpansion controlVSAvoidfolding structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The device employs self-service expansion mechanisms where the gel-forming material automatically expands upon contact with gastric fluids without requiring external control systems. The folded structure itself serves as the expansion mechanism, utilizing the natural swelling properties of the gel to drive the unfolding and expansion process, thereby achieving reliable controlled expansion while minimizing device complexity

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device effectively reduces stomach volume and increases satiety by expanding to apply pressure on stomach walls, promoting weight loss and satiety through controlled expansion and degradation.

Implementation Method 1

The gel-forming material is configured for swelling upon contact with liquid (e.g. liquid in the stomach that permeates through the liquid-permeable layers after ingestion of the device) to irreversibly switch the device from the first folded state to the expanded state

Methodology Applied
Scientific EffectSwelling: Hydrogel

Implementation Method 2

liquid in the stomach that permeates through the liquid-permeable layers after ingestion of the device

Methodology Applied
Scientific EffectPermeation: Permeation

Data Source

PatentUS12491099B2Intragastric expandable devices
Publication Date: 2025.12.09 EPITOMEE MEDICAL LTD
  • US12491099B2 patent drawing
  • US12491099B2 patent drawing
  • US12491099B2 patent drawing

AI summary

The disclosure provides a biodegradable device, administered to a patient in a compact ingestible encapsulated form. The device is self-expandable in the stomach upon contact with liquid, to assume an expanded, voluminous configuration within the stomach. The devices have a folded configuration in which intake is facilitated by the patient, and are designed to unfold and self-expand in the stomach after intake due to expansion of a plurality of expandable zones that comprise one or more gel-forming materials. The disclosure provides such devices, methods of their manufacture, as well as base units thereof.